Sonoma Pharmaceuticals, Inc.
SNOA
$2.79
$0.8040.20%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 5.24M | 4.08M | 2.59M | 3.13M | 2.41M |
Total Receivables | 2.61M | 3.38M | 3.48M | 3.16M | 3.13M |
Inventory | 3.14M | 2.84M | 2.66M | 2.72M | 2.96M |
Prepaid Expenses | 1.39M | 1.93M | 3.20M | 3.54M | 4.01M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 12.38M | 12.22M | 11.93M | 12.55M | 12.50M |
|
|||||
Total Current Assets | 12.38M | 12.22M | 11.93M | 12.55M | 12.50M |
Net Property, Plant & Equipment | 334.00K | 417.00K | 518.00K | 651.00K | 738.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 954.00K | 1.05M | 1.23M | 1.54M | 1.38M |
Total Assets | 13.67M | 13.69M | 13.67M | 14.74M | 14.62M |
|
|||||
Total Accounts Payable | 1.40M | 770.00K | 751.00K | 607.00K | 864.00K |
Total Accrued Expenses | 1.92M | 2.02M | 2.23M | 1.42M | 1.85M |
Short-term Debt | -- | 82.00K | 204.00K | 323.00K | 44.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 90.00K | 116.00K | 155.00K | 198.00K | 181.00K |
Total Finance Division Other Current Liabilities | 302.00K | 319.00K | 413.00K | 1.17M | 138.00K |
Total Other Current Liabilities | 302.00K | 319.00K | 413.00K | 1.17M | 138.00K |
Total Current Liabilities | 3.70M | 3.31M | 3.75M | 3.72M | 3.07M |
|
|||||
Total Current Liabilities | 3.70M | 3.31M | 3.75M | 3.72M | 3.07M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | 82.00K | 204.00K | 323.00K | 44.00K |
Capital Leases | 29.00K | 46.00K | 61.00K | 87.00K | 160.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.07M | 4.98M | 4.89M | 4.80M | 4.69M |
Total Liabilities | 8.80M | 8.33M | 8.70M | 8.60M | 7.93M |
|
|||||
Common Stock & APIC | 206.45M | 205.65M | 204.07M | 203.21M | 202.80M |
Retained Earnings | -197.03M | -196.10M | -195.49M | -194.35M | -193.28M |
Treasury Stock & Other | -4.55M | -4.20M | -3.60M | -2.72M | -2.82M |
Total Common Equity | 4.87M | 5.35M | 4.98M | 6.14M | 6.69M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.87M | 5.35M | 4.98M | 6.14M | 6.69M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.87M | 5.35M | 4.98M | 6.14M | 6.69M |
|